WCM
BMY icon

Weston Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Weston Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$616K Hold
11,590
– – 0.76% 26
2013
Q3 		$536K Hold
11,590
– – 0.7% 25
2013
Q2 		$518K Buy
+11,590
New +$503K 0.69% 24

Other funds holding BMY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Weston Capital Management's BMY Position: Q4 2013 in Review

Weston Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q4 2013 at 11,590 shares worth $616K. The position accounts for 0.76% of the portfolio, ranked #26.

Weston Capital Management first reported a position in BMY in Q2 2013 and has held it in 3 quarters since. 1,314 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

  • Weston Capital Management held 11,590 shares of Bristol-Myers Squibb worth $616K as of Q4 2013.
  • Weston Capital Management left its Bristol-Myers Squibb share count unchanged in Q4 2013.
  • Bristol-Myers Squibb made up 0.76% of Weston Capital Management's portfolio in Q4 2013, its #26 holding.
  • Weston Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 3 quarters since.
  • 1,314 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on Weston Capital Management's 13F filing for Q4 2013, filed 3 Jan 2014.